A Randomized, Double-Blind, Placebo-Controlled, Phase 111 Trial of 2 Regimens of Telaprevir (With and Without Delayed. Grant uri icon

date/time interval

  • October 10, 2008 - October 6, 2010

total award amount

  • 119738.00

direct costs

  • 95790.40

sponsor award ID

  • VX950-TID24-C216

local award ID

  • 00071001